A First-in-human Study of 3H-10000 in Patients With Unresectable or Metastatic Solid Tumors
A First-in-human Study of 3H-10000 in Patients With Unresectable or Metastatic Solid Tumors
Recruiting · NCT07354711 · Registry updated 2026-01-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A First-in-human Study of 3H-10000 in Patients With Unresectable or Metastatic Solid Tumors | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Thoracic Neoplasms, digestive system disorder, digestive system neoplasm, gastric cancer, gastric neoplasm, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, stomach disorder | Recruiting | Phase 1 / Phase 2 | 2026-01-21 | NCT07354711 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| 3H Pharmaceuticals Co., Ltd. | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Cancer Hospital | Beijing | China | 208 |